EUVIMEDEUVIMED entdecken
Crossref

Four-year Outcomes of Neoadjuvant Chemoimmunotherapy vs. Chemoradiotherapy in Resectable Esophageal Squamous Cell Carcinoma: A Multicenter Real-World Study

X. Zheng, H. Ge, S. Yang, W. Zhang, H. Wang, X. Wang, H. Liu, X.M. Wang

International Journal of Radiation Oncology*Biology*Physics · 2026-09 · 126 (1) · e32

DOI: 10.1016/j.ijrobp.2026.06.723 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2026-09. Verfasst von X. Zheng und 7 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Zheng, X., Ge, H., Yang, S., Zhang, W., Wang, H., Wang, X., Liu, H., & Wang, X. (2026). Four-year Outcomes of Neoadjuvant Chemoimmunotherapy vs. Chemoradiotherapy in Resectable Esophageal Squamous Cell Carcinoma: A Multicenter Real-World Study. International Journal of Radiation Oncology*Biology*Physics, 126(1), e32. https://doi.org/10.1016/j.ijrobp.2026.06.723

Vancouver

Zheng X, Ge H, Yang S, Zhang W, Wang H, Wang X, et al. Four-year Outcomes of Neoadjuvant Chemoimmunotherapy vs. Chemoradiotherapy in Resectable Esophageal Squamous Cell Carcinoma: A Multicenter Real-World Study. International Journal of Radiation Oncology*Biology*Physics. 2026;126(1):e32. doi:10.1016/j.ijrobp.2026.06.723

BibTeX
@article{Zheng2026,
  author = {Zheng, X. and Ge, H. and Yang, S. and Zhang, W. and Wang, H. and Wang, X. and Liu, H. and Wang, X.M.},
  title = {Four-year Outcomes of Neoadjuvant Chemoimmunotherapy vs. Chemoradiotherapy in Resectable Esophageal Squamous Cell Carcinoma: A Multicenter Real-World Study},
  journal = {International Journal of Radiation Oncology*Biology*Physics},
  year = {2026},
  volume = {126},
  number = {1},
  pages = {e32},
  doi = {10.1016/j.ijrobp.2026.06.723}
}
Kostenlos starten →